)
Visual
earnings real time
Mirum Pharmaceuticals (MIRM) investor relations material
Mirum Pharmaceuticals M&A Announcement summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.M&A Announcement summary8 Dec, 2025
Deal rationale and strategic fit
Acquisition expands leadership in rare diseases, particularly rare liver disorders, by adding a late-stage asset for chronic hepatitis delta virus (HDV) to the portfolio and advancing the late-stage pipeline for overlooked conditions with high unmet need.
Brelovitug, the acquired anti-hepatitis B surface antigen monoclonal antibody, is highly synergistic with existing expertise and leverages established relationships in the rare liver disease community.
The deal aligns with the strategy to deliver breakthrough medicines, unlocks significant value for patients, and leverages existing commercialization capabilities.
The acquisition is expected to deepen relationships with key stakeholders and provide a fourth potential registrational readout within 18 months.
Financial terms and conditions
Purchase price includes $250 million in cash and $370 million in stock at $71.21 per share, plus up to $200 million in tiered sales-based milestone payments starting at $500 million in annual sales.
Private placement to raise approximately $200 million at $68.48 per share to fund the transaction.
Mirum remains financially independent with $378 million in cash, equivalents, and investments.
Low single-digit royalty and minimal milestones owed to Novartis for background license.
Synergies and expected cost savings
Significant synergies anticipated by leveraging existing commercial operations, infrastructure, and rare liver expertise.
Operational efficiency and disciplined execution expected to maintain over 50% commercial margins.
Only modest incremental additions to field teams expected, maximizing operating leverage.
How does Brelovitug fit Mirum's commercial model
Brelovitug's path to accelerated approval
How does private placement impact financials
AZURE 1 interim data: What is its key purpose?
Strategies to boost US HDV diagnosis rates
Brelovitug's core competitive advantages?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Mirum Pharmaceuticals earnings date
Q4 202526 Feb, 2026
Next Mirum Pharmaceuticals earnings date
Q4 202526 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for rare liver diseases. The company targets conditions that primarily affect children and adults with limited treatment options. Mirum’s therapeutic approach addresses disorders related to bile acid metabolism, aiming to improve liver function and quality of life for patients. The company's portfolio includes both approved treatments and investigational therapies designed to manage chronic liver diseases. The company is headquartered in Foster City, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage